{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T02:04:18Z","timestamp":1792461858199,"version":"4.5.0"},"reference-count":97,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"vor","delay-in-days":306,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000928","name":"Welch Foundation","doi-asserted-by":"publisher","award":["I-1612"],"award-info":[{"award-number":["I-1612"]}],"id":[{"id":"10.13039\/100000928","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000928","name":"Welch Foundation","doi-asserted-by":"publisher","award":["I-1257"],"award-info":[{"award-number":["I-1257"]}],"id":[{"id":"10.13039\/100000928","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016820","name":"National Institute of Allergy and Infectious Diseases Vaccine Research Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016820","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["E01 W81XWH2210520"],"award-info":[{"award-number":["E01 W81XWH2210520"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004167","name":"Medicines for Malaria Venture","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004167","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP220582"],"award-info":[{"award-number":["RP220582"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Chemical Biology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.chembiol.2024.07.001","type":"journal-article","created":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T11:10:11Z","timestamp":1722337811000},"page":"1503-1517.e19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Identification of potent and reversible piperidine carboxamides that are species-selective orally active proteasome inhibitors to treat malaria"],"prefix":"10.1016","volume":"31","author":[{"given":"Aloysus","family":"Lawong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suraksha","family":"Gahalawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sneha","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nhi","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt E.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyi","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwani","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varun","family":"Hosangadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate J.","family":"Fairhurst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyuto","family":"Tashiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glen","family":"Liszczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Shackleford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasiram","family":"Katneni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elly","family":"Crighton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Casas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua J.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah S.","family":"Imlay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Lemoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I\u00f1igo","family":"Angulo-Barturen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Bel\u00e9n","family":"Jim\u00e9nez-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Wittlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon F.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Fidock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beno\u00eet","family":"Laleu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan A.","family":"Charman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"Ready","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5250-5578","authenticated-orcid":false,"given":"Margaret A.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chembiol.2024.07.001_bib1","doi-asserted-by":"crossref","first-page":"17050","DOI":"10.1038\/nrdp.2017.50","article-title":"Malaria","volume":"3","author":"Phillips","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.chembiol.2024.07.001_bib2","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1016\/S0140-6736(23)01249-7","article-title":"Malaria","volume":"402","author":"Poespoprodjo","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.chembiol.2024.07.001_bib4","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/S1473-3099(20)30228-0","article-title":"Molecular epidemiology of resistance to antimalarial drugs in the Greater Mekong subregion: an observational study","volume":"20","author":"Imwong","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.chembiol.2024.07.001_bib5","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/cid\/ciw388","article-title":"Declining Efficacy of Artemisinin Combination Therapy Against P. Falciparum Malaria on the Thai-Myanmar Border (2003-2013): The Role of Parasite Genetic Factors","volume":"63","author":"Phyo","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.chembiol.2024.07.001_bib6","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1056\/NEJMoa2211803","article-title":"Evolution of Partial Resistance to Artemisinins in Malaria Parasites in Uganda","volume":"389","author":"Conrad","year":"2023","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.chembiol.2024.07.001_bib7","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1056\/NEJMoa2210956","article-title":"Increasing Prevalence of Artemisinin-Resistant HRP2-Negative Malaria in Eritrea","volume":"389","author":"Mihreteab","year":"2023","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.chembiol.2024.07.001_bib8","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41573-023-00772-9","article-title":"Antimalarial drug discovery: progress and approaches","volume":"22","author":"Siqueira-Neto","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.chembiol.2024.07.001_bib9","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/cid\/ciab716","article-title":"Efficacy of Cipargamin (KAE609) in a Randomized, Phase II Dose-Escalation Study in Adults in Sub-Saharan Africa With Uncomplicated Plasmodium falciparum Malaria","volume":"74","author":"Schmitt","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.chembiol.2024.07.001_bib10","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S1473-3099(19)30611-5","article-title":"Safety, tolerability, pharmacokinetics, and antimalarial efficacy of a novel Plasmodium falciparum ATP4 inhibitor SJ733: a first-in-human and induced blood-stage malaria phase 1a\/b trial","volume":"20","author":"Gaur","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.chembiol.2024.07.001_bib11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4269\/ajtmh.22-0567","article-title":"Efficacy, Safety, Tolerability, and Pharmacokinetics of MMV390048 in Acute Uncomplicated Malaria","volume":"108","author":"Mohammed","year":"2023","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.chembiol.2024.07.001_bib12","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/S1473-3099(18)30309-8","article-title":"Antimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum or Plasmodium vivax malaria infection: a proof-of-concept, open-label, phase 2a study","volume":"18","author":"Llanos-Cuentas","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.chembiol.2024.07.001_bib13","doi-asserted-by":"crossref","first-page":"296ra111","DOI":"10.1126\/scitranslmed.aaa6645","article-title":"A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria","volume":"7","author":"Phillips","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.chembiol.2024.07.001_bib14","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S1473-3099(21)00252-8","volume":"21","author":"McCarthy","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.chembiol.2024.07.001_bib15","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S1473-3099(23)00209-8","article-title":"Ganaplacide (KAF156) plus lumefantrine solid dispersion formulation combination for uncomplicated Plasmodium falciparum malaria: an open-label, multicentre, parallel-group, randomised, controlled, phase 2 trial","volume":"23","author":"Ogutu","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.chembiol.2024.07.001_bib16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.mib.2020.06.004","article-title":"The antimalarial resistome - finding new drug targets and their modes of action","volume":"57","author":"Carolino","year":"2020","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.chembiol.2024.07.001_bib17","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1080\/14728222.2019.1685981","article-title":"The proteasome as a target for protozoan parasites","volume":"23","author":"Xie","year":"2019","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.chembiol.2024.07.001_bib18","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nrclinonc.2016.206","article-title":"Proteasome inhibitors in cancer therapy","volume":"14","author":"Manasanch","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.chembiol.2024.07.001_bib19","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.pt.2017.05.009","article-title":"Protein Degradation Systems as Antimalarial Therapeutic Targets","volume":"33","author":"Ng","year":"2017","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.chembiol.2024.07.001_bib20","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.trsl.2018.04.007","article-title":"The proteasome as a target to combat malaria: hits and misses","volume":"198","author":"Krishnan","year":"2018","journal-title":"Transl. Res."},{"key":"10.1016\/j.chembiol.2024.07.001_bib21","doi-asserted-by":"crossref","first-page":"630888","DOI":"10.3389\/fchem.2020.630888","article-title":"Ubiquitination and the Proteasome as Drug Targets in Trypanosomatid Diseases","volume":"8","author":"Bijlmakers","year":"2020","journal-title":"Front. Chem."},{"key":"10.1016\/j.chembiol.2024.07.001_bib22","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1021\/acs.jmedchem.2c01651","article-title":"Structure-Activity Relationship Studies of Antimalarial Plasmodium Proteasome Inhibitors\u2014Part II","volume":"66","author":"Zhang","year":"2023","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.chembiol.2024.07.001_bib23","doi-asserted-by":"crossref","first-page":"9350","DOI":"10.1021\/acs.jmedchem.2c00611","article-title":"Design, Synthesis, and Optimization of Macrocyclic Peptides as Species-Selective Antimalaria Proteasome Inhibitors","volume":"65","author":"Zhang","year":"2022","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.chembiol.2024.07.001_bib24","doi-asserted-by":"crossref","first-page":"9279","DOI":"10.1002\/anie.202015845","article-title":"Development of a Highly Selective Plasmodium falciparum Proteasome Inhibitor with Anti-malaria Activity in Humanized Mice","volume":"60","author":"Zhan","year":"2021","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.chembiol.2024.07.001_bib25","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2107213118","article-title":"Design of proteasome inhibitors with oral efficacy in\u00a0vivo against Plasmodium falciparum and selectivity over the human proteasome","volume":"118","author":"Xie","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2024.07.001_bib26","doi-asserted-by":"crossref","first-page":"11424","DOI":"10.1021\/jacs.8b06656","article-title":"Defining the Determinants of Specificity of Plasmodium Proteasome Inhibitors","volume":"140","author":"Yoo","year":"2018","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.chembiol.2024.07.001_bib27","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1021\/acsinfecdis.2c00527","article-title":"Fast-Killing Tyrosine Amide ((S)-SW228703) with Blood- and Liver-Stage Antimalarial Activity Associated with the Cyclic Amine Resistance Locus (PfCARL)","volume":"9","author":"Imlay","year":"2023","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.chembiol.2024.07.001_bib28","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1021\/acs.jmedchem.0c02022","article-title":"Novel Antimalarial Tetrazoles and Amides Active against the Hemoglobin Degradation Pathway in Plasmodium falciparum","volume":"64","author":"Lawong","year":"2021","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.chembiol.2024.07.001_bib29","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12936-016-1675-x","article-title":"New developments in anti-malarial target candidate and product profiles","volume":"16","author":"Burrows","year":"2017","journal-title":"Malar. J."},{"key":"10.1016\/j.chembiol.2024.07.001_bib30","first-page":"717","article-title":"A validated bioluminescence-based assay for the rapid determination of the initial rate of kill for discovery antimalarials","volume":"72","author":"Ullah","year":"2017","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.chembiol.2024.07.001_bib31","doi-asserted-by":"crossref","first-page":"11901","DOI":"10.1038\/ncomms11901","article-title":"A broad analysis of resistance development in the malaria parasite","volume":"7","author":"Corey","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chembiol.2024.07.001_bib32","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/978-1-4939-9550-9_9","article-title":"Plasmodium falciparum In\u00a0Vitro Drug Resistance Selections and Gene Editing","volume":"2013","author":"Ng","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.chembiol.2024.07.001_bib33","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.pt.2021.04.006","article-title":"Assessing risks of Plasmodium falciparum resistance to select next-generation antimalarials","volume":"37","author":"Duffey","year":"2021","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.chembiol.2024.07.001_bib34","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13073-019-0673-3","article-title":"Advances in omics-based methods to identify novel targets for malaria and other parasitic protozoan infections","volume":"11","author":"Cowell","year":"2019","journal-title":"Genome Med."},{"key":"10.1016\/j.chembiol.2024.07.001_bib35","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.molcel.2019.07.014","article-title":"Characterization of Fully Recombinant Human 20S and 20S-PA200 Proteasome Complexes","volume":"76","author":"Toste Rego","year":"2019","journal-title":"Mol Cell"},{"key":"10.1016\/j.chembiol.2024.07.001_bib36","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nature16936","article-title":"Structure- and function-based design of Plasmodium-selective proteasome inhibitors","volume":"530","author":"Li","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2024.07.001_bib37","doi-asserted-by":"crossref","first-page":"E6863","DOI":"10.1073\/pnas.1806109115","article-title":"Antimalarial proteasome inhibitor reveals collateral sensitivity from intersubunit interactions and fitness cost of resistance","volume":"115","author":"Kirkman","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2024.07.001_bib38","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1126\/science.aaf8993","article-title":"The inhibition mechanism of human 20S proteasomes enables next-generation inhibitor design","volume":"353","author":"Schrader","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2024.07.001_bib39","doi-asserted-by":"crossref","first-page":"8302","DOI":"10.1038\/s41467-023-44077-2","article-title":"Structures revealing mechanisms of resistance and collateral sensitivity of Plasmodium falciparum to proteasome inhibitors","volume":"14","author":"Hsu","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chembiol.2024.07.001_bib40","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.cell.2011.12.030","article-title":"Immuno- and constitutive proteasome crystal structures reveal differences in substrate and inhibitor specificity","volume":"148","author":"Huber","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.chembiol.2024.07.001_bib41","doi-asserted-by":"crossref","first-page":"104862","DOI":"10.1016\/j.jbc.2023.104862","article-title":"\u0397igh-resolution structure of mammalian PI31-20S proteasome complex reveals mechanism of proteasome inhibition","volume":"299","author":"Hsu","year":"2023","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chembiol.2024.07.001_bib42","doi-asserted-by":"crossref","first-page":"9318","DOI":"10.1073\/pnas.1820175116","article-title":"Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition","volume":"116","author":"Wyllie","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2024.07.001_bib43","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.chembiol.2023.03.002","article-title":"Mitigating the risk of antimalarial resistance via covalent dual-subunit inhibition of the Plasmodium proteasome","volume":"30","author":"Deni","year":"2023","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.chembiol.2024.07.001_bib44","article-title":"Development of Potent and Highly Selective Epoxyketone-Based Plasmodium Proteasome Inhibitors","volume":"29","author":"Almaliti","year":"2023","journal-title":"Chemistry"},{"key":"10.1016\/j.chembiol.2024.07.001_bib45","doi-asserted-by":"crossref","first-page":"e30949","DOI":"10.1371\/journal.pone.0030949","article-title":"P.\u00a0falciparum in\u00a0vitro killing rates allow to discriminate between different antimalarial mode-of-action","volume":"7","author":"Sanz","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.chembiol.2024.07.001_bib46","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01574-22","article-title":"Predicting Optimal Antimalarial Drug Combinations from a Standardized Plasmodium falciparum Humanized Mouse Model","volume":"67","author":"Demarta-Gatsi","year":"2023","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.chembiol.2024.07.001_bib47","doi-asserted-by":"crossref","first-page":"10773","DOI":"10.1021\/acs.jmedchem.0c00499","article-title":"Discovery and Characterization of Clinical Candidate LXE408 as a Kinetoplastid-Selective Proteasome Inhibitor for the Treatment of Leishmaniases","volume":"63","author":"Nagle","year":"2020","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.chembiol.2024.07.001_bib48","doi-asserted-by":"crossref","first-page":"10413","DOI":"10.1021\/acs.jmedchem.3c00582","article-title":"Structure-Guided Design and Synthesis of a Pyridazinone Series of Trypanosoma cruzi Proteasome Inhibitors","volume":"66","author":"Thomas","year":"2023","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.chembiol.2024.07.001_bib49","doi-asserted-by":"crossref","first-page":"11776","DOI":"10.1021\/acs.jmedchem.2c00791","article-title":"Discovery of Novel Quinoline-Based Proteasome Inhibitors for Human African Trypanosomiasis (HAT)","volume":"65","author":"Koester","year":"2022","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.chembiol.2024.07.001_bib50","doi-asserted-by":"crossref","first-page":"e02312-20","DOI":"10.1128\/mBio.02312-20","article-title":"Plasmodium berghei K13 Mutations Mediate In\u00a0Vivo Artemisinin Resistance That Is Reversed by Proteasome Inhibition","volume":"11","author":"Simwela","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.chembiol.2024.07.001_bib51","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1038\/s41467-018-06221-1","article-title":"Artemisinin kills malaria parasites by damaging proteins and inhibiting the proteasome","volume":"9","author":"Bridgford","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chembiol.2024.07.001_bib52","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.chembiol.2012.09.019","article-title":"Validation of the proteasome as a therapeutic target in Plasmodium using an epoxyketone inhibitor with parasite-specific toxicity","volume":"19","author":"Li","year":"2012","journal-title":"Chem. Biol."},{"key":"10.1016\/j.chembiol.2024.07.001_bib53","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0076-6879(05)99040-X","article-title":"Screening for selective small molecule inhibitors of the proteasome using activity-based probes","volume":"399","author":"Bogyo","year":"2005","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.chembiol.2024.07.001_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007722","article-title":"Covalent Plasmodium falciparum-selective proteasome inhibitors exhibit a low propensity for generating resistance in\u00a0vitro and synergize with multiple antimalarial agents","volume":"15","author":"Stokes","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.chembiol.2024.07.001_bib55","doi-asserted-by":"crossref","first-page":"10053","DOI":"10.1021\/acs.jmedchem.8b01161","article-title":"Target Validation and Identification of Novel Boronate Inhibitors of the Plasmodium falciparum Proteasome","volume":"61","author":"Xie","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.chembiol.2024.07.001_bib56","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1021\/acsinfecdis.3c00310","article-title":"Covalent Macrocyclic Proteasome Inhibitors Mitigate Resistance in Plasmodium falciparum","volume":"9","author":"Bennett","year":"2023","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.chembiol.2024.07.001_bib57","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1021\/acs.chemrev.0c00648","article-title":"Drug Design Strategies to Avoid Resistance in Direct-Acting Antivirals and Beyond","volume":"121","author":"Matthew","year":"2021","journal-title":"Chem. Rev."},{"key":"10.1016\/j.chembiol.2024.07.001_bib58","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.exppara.2006.12.003","article-title":"In\u00a0vitro cultivation of Plasmodium falciparum: studies with modified medium supplemented with ALBUMAX II and various animal sera","volume":"116","author":"Srivastava","year":"2007","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.chembiol.2024.07.001_bib59","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1128\/AAC.48.5.1807-1810.2004","article-title":"Novel, rapid, and inexpensive cell-based quantification of antimalarial drug efficacy","volume":"48","author":"Bennett","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.chembiol.2024.07.001_bib60","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1128\/AAC.48.5.1803-1806.2004","article-title":"Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening","volume":"48","author":"Smilkstein","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.chembiol.2024.07.001_bib61","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.exppara.2010.08.007","article-title":"In-vitro culture of Plasmodium falciparum: utility of modified (RPNI) medium for drug-sensitivity studies using SYBR Green I assay","volume":"127","author":"Singh","year":"2011","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.chembiol.2024.07.001_bib62","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1128\/AAC.48.11.4097-4102.2004","article-title":"Modified fixed-ratio isobologram method for studying in\u00a0vitro interactions between atovaquone and proguanil or dihydroartemisinin against drug-resistant strains of Plasmodium falciparum","volume":"48","author":"Fivelman","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.chembiol.2024.07.001_bib63","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.exppara.2006.09.016","article-title":"In\u00a0vitro and in\u00a0vivo interaction of synthetic peroxide RBx11160 (OZ277) with piperaquine in Plasmodium models","volume":"115","author":"Snyder","year":"2007","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.chembiol.2024.07.001_bib64","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00017-23","article-title":"Modified Plasmodium falciparum Ring-Stage Survival Assay with ML10 Kinase Inhibitor","volume":"67","author":"Platon","year":"2023","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.chembiol.2024.07.001_bib65","first-page":"159","article-title":"Extraction and purification of Plasmodium parasite DNA","volume":"72","author":"Beck","year":"2002","journal-title":"Methods Mol. Med."},{"key":"10.1016\/j.chembiol.2024.07.001_bib66","author":"Andrews"},{"key":"10.1016\/j.chembiol.2024.07.001_bib67","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.12688\/f1000research.15931.1","article-title":"FastQ Screen: A tool for multi-genome mapping and quality control","volume":"7","author":"Wingett","year":"2018","journal-title":"F1000Res."},{"key":"10.1016\/j.chembiol.2024.07.001_bib68","article-title":"Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM","author":"Li","year":"2013","journal-title":"arXiv"},{"key":"10.1016\/j.chembiol.2024.07.001_bib69","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4161\/fly.19695","article-title":"A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3","volume":"6","author":"Cingolani","year":"2012","journal-title":"Fly (Austin)"},{"key":"10.1016\/j.chembiol.2024.07.001_bib70","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/bioinformatics\/btr670","article-title":"Control-FREEC: a tool for assessing copy number and allelic content using next-generation sequencing data","volume":"28","author":"Boeva","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.chembiol.2024.07.001_bib71","doi-asserted-by":"crossref","DOI":"10.1111\/cmi.12719","article-title":"The chaperonin TRiC forms an oligomeric complex in the malaria parasite cytosol","volume":"19","author":"Spillman","year":"2017","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.chembiol.2024.07.001_bib72","author":"Pellegrini"},{"key":"10.1016\/j.chembiol.2024.07.001_bib73","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/nprot.2007.132","article-title":"Gene splicing and mutagenesis by PCR-driven overlap extension","volume":"2","author":"Heckman","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.chembiol.2024.07.001_bib74","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1093\/nar\/29.3.850","article-title":"Transformation of malaria parasites by the spontaneous uptake and expression of DNA from human erythrocytes","volume":"29","author":"Deitsch","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.chembiol.2024.07.001_bib75","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jsb.2005.07.007","article-title":"Automated electron microscope tomography using robust prediction of specimen movements","volume":"152","author":"Mastronarde","year":"2005","journal-title":"J.\u00a0Struct. Biol."},{"key":"10.1016\/j.chembiol.2024.07.001_bib76","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1107\/S2059798316019276","article-title":"A pipeline approach to single-particle processing in RELION","volume":"73","author":"Fernandez-Leiro","year":"2017","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"10.1016\/j.chembiol.2024.07.001_bib77","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1042\/BCJ20210708","article-title":"New tools for automated cryo-EM single-particle analysis in RELION-4.0","volume":"478","author":"Kimanius","year":"2021","journal-title":"Biochem. J."},{"key":"10.1016\/j.chembiol.2024.07.001_bib78","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jsb.2012.09.006","article-title":"RELION: implementation of a Bayesian approach to cryo-EM structure determination","volume":"180","author":"Scheres","year":"2012","journal-title":"J.\u00a0Struct. Biol."},{"key":"10.1016\/j.chembiol.2024.07.001_bib79","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nmeth.4193","article-title":"MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy","volume":"14","author":"Zheng","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.chembiol.2024.07.001_bib80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsb.2015.11.003","article-title":"Gctf: Real-time CTF determination and correction","volume":"193","author":"Zhang","year":"2016","journal-title":"J.\u00a0Struct. Biol."},{"key":"10.1016\/j.chembiol.2024.07.001_bib81","author":"Zhang"},{"key":"10.1016\/j.chembiol.2024.07.001_bib82","doi-asserted-by":"crossref","first-page":"7573","DOI":"10.1038\/ncomms8573","article-title":"Cryo-EM reveals the conformation of a substrate analogue in the human 20S proteasome core","volume":"6","author":"da Fonseca","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chembiol.2024.07.001_bib83","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.str.2011.12.014","article-title":"Outcome of the first electron microscopy validation task force meeting","volume":"20","author":"Henderson","year":"2012","journal-title":"Structure"},{"key":"10.1016\/j.chembiol.2024.07.001_bib84","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1107\/S2059798319011471","article-title":"Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix","volume":"75","author":"Liebschner","year":"2019","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"10.1016\/j.chembiol.2024.07.001_bib85","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.chembiol.2024.07.001_bib86","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/pro.3330","article-title":"MolProbity: More and better reference data for improved all-atom structure validation","volume":"27","author":"Williams","year":"2018","journal-title":"Protein Sci."},{"key":"10.1016\/j.chembiol.2024.07.001_bib87","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/pro.3943","article-title":"UCSF ChimeraX: Structure visualization for researchers, educators, and developers","volume":"30","author":"Pettersen","year":"2021","journal-title":"Protein Sci."},{"key":"10.1016\/j.chembiol.2024.07.001_bib88","doi-asserted-by":"crossref","first-page":"e66967","DOI":"10.1371\/journal.pone.0066967","article-title":"A new in\u00a0vivo screening paradigm to accelerate antimalarial drug discovery","volume":"8","author":"Jimenez-Diaz","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.chembiol.2024.07.001_bib89","doi-asserted-by":"crossref","first-page":"4533","DOI":"10.1128\/AAC.00519-09","article-title":"Improved murine model of malaria using Plasmodium falciparum competent strains and non-myelodepleted NOD-scid IL2Rgammanull mice engrafted with human erythrocytes","volume":"53","author":"Jimenez-Diaz","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.chembiol.2024.07.001_bib90","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/cyto.a.20647","article-title":"Quantitative measurement of Plasmodium-infected erythrocytes in murine models of malaria by flow cytometry using bidimensional assessment of SYTO-16 fluorescence","volume":"75","author":"Jimenez-Diaz","year":"2009","journal-title":"Cytometry"},{"key":"10.1016\/j.chembiol.2024.07.001_bib91","doi-asserted-by":"crossref","first-page":"6085","DOI":"10.1021\/acs.jmedchem.1c00173","article-title":"Potent Antimalarials with Development Potential Identified by Structure-Guided Computational Optimization of a Pyrrole-Based Dihydroorotate Dehydrogenase Inhibitor Series","volume":"64","author":"Palmer","year":"2021","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.chembiol.2024.07.001_bib92","doi-asserted-by":"crossref","first-page":"e2252","DOI":"10.1371\/journal.pone.0002252","article-title":"A murine model of falciparum-malaria by in\u00a0vivo selection of competent strains in non-myelodepleted mice engrafted with human erythrocytes","volume":"3","author":"Angulo-Barturen","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.chembiol.2024.07.001_bib93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-019-3075-5","article-title":"An in\u00a0vitro toolbox to accelerate anti-malarial drug discovery and\u00a0development","volume":"19","author":"Charman","year":"2020","journal-title":"Malar. J."},{"key":"10.1016\/j.chembiol.2024.07.001_bib94","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1124\/dmd.105.004259","article-title":"A unified model for predicting human hepatic, metabolic clearance from in\u00a0vitro intrinsic clearance data in hepatocytes and microsomes","volume":"33","author":"Riley","year":"2005","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.chembiol.2024.07.001_bib95","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1124\/dmd.30.12.1497","article-title":"The influence of nonspecific microsomal binding on apparent intrinsic clearance, and its prediction from physicochemical properties","volume":"30","author":"Austin","year":"2002","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.chembiol.2024.07.001_bib96","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1124\/dmd.104.002436","article-title":"The binding of drugs to hepatocytes and its relationship to physicochemical properties","volume":"33","author":"Austin","year":"2005","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.chembiol.2024.07.001_bib97","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1007\/s11095-022-03205-1","article-title":"In\u00a0Vitro - in\u00a0Vivo Extrapolation of Hepatic Clearance in Preclinical Species","volume":"39","author":"Tess","year":"2022","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.chembiol.2024.07.001_bib98","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.chembiol.2006.09.013","article-title":"A fluorescent broad-spectrum proteasome inhibitor for labeling proteasomes in\u00a0vitro and in\u00a0vivo","volume":"13","author":"Verdoes","year":"2006","journal-title":"Chem. Biol."}],"container-title":["Cell Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451945624002782?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451945624002782?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T18:19:45Z","timestamp":1762625985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451945624002782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":97,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S2451945624002782"],"URL":"https:\/\/doi.org\/10.1016\/j.chembiol.2024.07.001","relation":{},"ISSN":["2451-9456"],"issn-type":[{"value":"2451-9456","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of potent and reversible piperidine carboxamides that are species-selective orally active proteasome inhibitors to treat malaria","name":"articletitle","label":"Article Title"},{"value":"Cell Chemical Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chembiol.2024.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}